Physician profile
Bopha Chrea
NPI 1942611025
$10,129.91
in general payments reported to CMS, 2019-2025
10 companies · $3,261 in 2025
The $3,261 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $628 · 2021: $1,765 · 2022: $923 · 2023: $2,729 · 2024: $824 · 2025: $3,261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,264 · Food and Beverage: $1,550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,264.35 |
| Food and Beverage | $1,549.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novastep INC. | $2,552.18 | 2021-2022 | |
| Paragon 28, INC. | $2,369.69 | 2024-2025 | Portfolio, Additive Orthopedics, Bun-Yo-Matic |
| Arthrex, INC. | $2,344.53 | 2021-2025 | |
| Steelhead Surgical INC | $1,912.61 | 2020-2023 | |
| Crossroads Orthopedics, LLC | $266.66 | 2023 | |
| Zimmer Biomet Holdings, INC. | $197.85 | 2025 | Trabecular Metal |
| Kerecis Limited | $182.46 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Stryker Corporation | $135.00 | 2023 | Infinity |
| Trimed, INC. | $134.57 | 2025 | |
| Depuy Synthes Sales INC. | $34.36 | 2023 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bopha Chrea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.